Does a Minimally Invasive Approach to Liver Resection Improve Postoperative Outcomes?

Mount Sinai Health System

Status: Completed

Conditions: Hepatic Neoplasms

Study type: Observational

Funder types: Other

Identifiers

NCT07169877

STUDY-25-00212

Details and patient eligibility

About

A retrospective cohort study was conducted using the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database to identify adult patients who underwent liver resection between 2022 and 2023. Primary outcomes included 30-day mortality, sepsis, septic shock, readmission, and reoperation.

Enrollment: 9,411 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

- Retrospective patients with condition only

Exclusion criteria

- none

Trial design

9,411 participants in 1 patient group

Participant who underwent liver resection

Description:

Adult patients who underwent liver resection between January 2022 and December 2023. Data obtained from the American College of Surgeons National Surgical Quality Improvement Program (NSQIP)